Craig I Coleman

Craig I Coleman

UNVERIFIED PROFILE

Are you Craig I Coleman?   Register this Author

Register author
Craig I Coleman

Craig I Coleman

Publications by authors named "Craig I Coleman"

Are you Craig I Coleman?   Register this Author

97Publications

1643Reads

7Profile Views

Safety and effectiveness of oral factor Xa inhibitors versus warfarin in nonvalvular atrial fibrillation patients at high-risk for falls.

J Thromb Thrombolysis 2019 Oct;48(3):366-372

Department of Pharmacy Practice and Evidence-Based Practice Center, University of Connecticut School of Pharmacy, 69 North Eagleville Road, Unit 3092, Storrs, CT, 06269, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11239-019-01898-7DOI Listing
October 2019

Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing Hemodialysis.

Am J Med 2019 Sep 2;132(9):1078-1083. Epub 2019 May 2.

Department of Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs; Evidence-Based Practice Center, Hartford Hospital, Hartford, Conn.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2019.04.013DOI Listing
September 2019

Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and coronary or peripheral artery disease.

Eur Heart J Cardiovasc Pharmacother 2019 Sep 6. Epub 2019 Sep 6.

Ayer Neuroscience Institute, Hartford HealthCare, 80 Seymour Street, Hartford, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ehjcvp/pvz047DOI Listing
September 2019

Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults.

J Am Geriatr Soc 2019 Aug 29;67(8):1571-1581. Epub 2019 May 29.

University of Connecticut School of Pharmacy, Storrs, Connecticut.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgs.15966DOI Listing
August 2019

Treatment patterns, glycemic control and bodyweight with canagliflozin 300 mg versus GLP1RAs in Type II diabetes patients.

J Comp Eff Res 2019 Aug 6;8(11):889-905. Epub 2019 Jun 6.

Janssen Scientific Affairs, LLC, Real World Value & Evidence, Titusville, NJ 08560, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cer-2019-0002DOI Listing
August 2019

Rivaroxaban's Impact on Renal Decline in Patients With Nonvalvular Atrial Fibrillation: A US MarketScan Claims Database Analysis.

Clin Appl Thromb Hemost 2019 Jan-Dec;25:1076029619868535

1 Department of Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1076029619868535DOI Listing
August 2019

Cost and inpatient burden of peripheral artery disease: Findings from the National Inpatient Sample.

Atherosclerosis 2019 Jul 27;286:142-146. Epub 2019 May 27.

Hartford Hospital, Hartford, CT, USA; University of Connecticut School of Pharmacy, Storrs, CT, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2019.05.026DOI Listing
July 2019

Proportion of US Hospitalized Medically Ill Patients Who May Qualify for Extended Thromboprophylaxis.

Clin Appl Thromb Hemost 2019 Jan-Dec;25:1076029619850897

1 Department of Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1076029619850897DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714926PMC
May 2019

Effectiveness and safety of rivaroxaban vs. warfarin in non-valvular atrial fibrillation patients with a non-sex-related CHA2DS2-VASc score of 1.

Eur Heart J Cardiovasc Pharmacother 2019 04;5(2):64-69

Department of Pharmacy Practice, University of Connecticut School of Pharmacy, 69 North Eagleville Road, Unit 3092, Storrs, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ehjcvp/pvy025DOI Listing
April 2019

Impact of Prolonged Anticoagulation with Rivaroxaban on Provoked Venous Thromboembolism Recurrence: IMPROVE-VTE.

Am J Med 2019 Apr 21;132(4):498-504. Epub 2018 Dec 21.

Thrombosis Research Unit, Department of Medicine I, Division Hematology, University Hospital Carl Gustav Carus, Dresden, Germany; Kings Thrombosis Service, Department of Hematology, Kings College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2018.11.040DOI Listing
April 2019

Can apixaban prevent venous thromboembolism better than rivaroxaban?

Lancet Haematol 2019 04;6(4):e179

School of Pharmacy and Evidence-Based Practice Center, University of Connecticut, Storrs, CT 06269, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(19)30022-5DOI Listing
April 2019

Systematic review and meta-analysis of catheter ablation of ventricular tachycardia in ischemic heart disease.

Heart Rhythm 2019 Apr 27. Epub 2019 Apr 27.

Hartford HealthCare Heart and Vascular Institute, Hartford Hospital, Hartford, Connecticut; University of Connecticut School of Medicine, Farmington, Connecticut. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hrthm.2019.04.024DOI Listing
April 2019

Outcomes of Hemorrhagic Stroke Patients with Atrial Fibrillation or Flutter.

J Atr Fibrillation 2019 Apr 30;11(6):2144. Epub 2019 Apr 30.

Idaho State University College of Pharmacy, Meridian, ID, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4022/jafib.2144DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652795PMC
April 2019

External validation of three risk stratification rules in patients presenting with pulmonary embolism and cancer.

Support Care Cancer 2019 Mar 8;27(3):921-925. Epub 2018 Aug 8.

University of Connecticut School of Medicine, Farmington, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-018-4380-1DOI Listing
March 2019

Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and heart failure.

ESC Heart Fail 2019 02 9;6(1):10-15. Epub 2018 Oct 9.

Department of Pharmacy Practice, University of Connecticut School of Pharmacy, 69 North Eagleville Road, Unit 3092, Storrs, CT, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ehf2.12365
Publisher Site
http://dx.doi.org/10.1002/ehf2.12365DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352884PMC
February 2019

Comparative risk of major bleeding with rivaroxaban and warfarin: Population-based cohort study of unprovoked venous thromboembolism.

Eur J Haematol 2019 Feb 20;102(2):143-149. Epub 2018 Nov 20.

Evidence-Based Practice Center, UCONN/Hartford Hospital, Hartford, Connecticut.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13185DOI Listing
February 2019

Influence of Polypharmacy on the Effectiveness and Safety of Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation.

Pharmacotherapy 2019 Feb 28;39(2):196-203. Epub 2019 Jan 28.

Department of Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, Connecticut.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/phar.2213DOI Listing
February 2019

Left ventricular assist device implantation improves glycaemic control: a systematic review and meta-analysis.

ESC Heart Fail 2018 12 27;5(6):1141-1149. Epub 2018 Jul 27.

Department of Pharmacy Practice, University of Connecticut School of Pharmacy, 69 N. Eagleville Rd, Unit 3092, Storrs, CT, 06269-3092, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ehf2.12337DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300809PMC
December 2018

Ranolazine in patients with type 2 diabetes and chronic angina: A cost-effectiveness analysis and assessment of health-related quality-of-life.

Int J Cardiol 2018 Dec 21;273:34-38. Epub 2018 Sep 21.

Medical University of South Carolina, College of Pharmacy, Charleston, SC, United States of America. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2018.09.060DOI Listing
December 2018

Effectiveness and safety of rivaroxaban vs. warfarin in patients 80+ years of age with non-valvular atrial fibrillation.

Eur Heart J Qual Care Clin Outcomes 2018 10;4(4):328-329

Department of Cardiac Electrophysiology, Southcoast Health System, Fall River, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ehjqcco/qcx044DOI Listing
October 2018

Effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism.

J Thromb Thrombolysis 2018 Oct;46(3):339-345

Thrombosis Research Unit, Department of Medicine I, Division Hematology, University Hospital "Carl Gustav Carus" Dresden, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11239-018-1695-1DOI Listing
October 2018

Effectiveness and Safety of Rivaroxaban Versus Warfarin in Frail Patients with Venous Thromboembolism.

Am J Med 2018 08 8;131(8):933-938.e1. Epub 2018 Mar 8.

Thrombosis Research Unit, Department of Medicine I, Division of Hematology, University Hospital "Carl Gustav Carus" Dresden, Dresden, Germany; Kings Thrombosis Service, Department of Hematology, Kings College London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2018.02.015DOI Listing
August 2018

Effectiveness and safety of rivaroxaban versus warfarin in patients with unprovoked venous thromboembolism: A propensity-score weighted administrative claims cohort study.

Thromb Res 2018 08 30;168:31-36. Epub 2018 May 30.

Thrombosis Research Unit, Division of Hematology, Department of Medicine I, Carl Gustav Carus University Hospital, Technische Universität Dresden, Dresden, Germany; King's Thrombosis Service, Department of Hematology, King's College London, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2018.05.031DOI Listing
August 2018

Rivaroxaban Versus Warfarin and Risk of Post-Thrombotic Syndrome Among Patients with Venous Thromboembolism.

Am J Med 2018 07 21;131(7):787-794.e4. Epub 2018 Feb 21.

Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Aalborg, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2018.01.041DOI Listing
July 2018

Meta-Analysis of Time in Therapeutic Range in Continuous-Flow Left Ventricular Assist Device Patients Receiving Warfarin.

Artif Organs 2018 Jul 6;42(7):700-704. Epub 2018 Mar 6.

Hartford Hospital, Department of Pharmacy, Hartford, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/aor.13116DOI Listing
July 2018

Systematic Review and Meta-Analysis of Real-World Studies Evaluating Rivaroxaban for Cancer-Associated Venous Thrombosis.

Pharmacotherapy 2018 06 10;38(6):610-618. Epub 2018 May 10.

University of Connecticut School of Pharmacy, Storrs, Connecticut.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/phar.2113DOI Listing
June 2018

Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism.

Clin Appl Thromb Hemost 2018 May 8;24(4):575-582. Epub 2018 Mar 8.

6 Department of Medicine, Anticoagulation and Clinical Thrombosis Services, Northwell Health System, Hofstra Northwell School of Medicine, Manhasset, NY, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1076029618758955
Publisher Site
http://dx.doi.org/10.1177/1076029618758955DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714693PMC
May 2018

Understanding the Value of Real-World Evidence: Focus on Stroke Prevention in Atrial Fibrillation with Rivaroxaban.

Thromb Haemost 2018 May 22;118(S 01):S45-S60. Epub 2018 Mar 22.

Naval Medical Center, Portsmouth, Virginia, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1635084DOI Listing
May 2018

Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation.

J Am Heart Assoc 2018 04 13;7(8). Epub 2018 Apr 13.

Department of Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, CT

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/JAHA.118.008643DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015429PMC
April 2018

Comparative Effectiveness and Safety of Apixaban and Vitamin K Antagonist Therapy in Patients With Nonvalvular Atrial Fibrillation Treated in Routine German Practice.

Heart Lung Circ 2018 Mar 3;27(3):390-393. Epub 2017 May 3.

Hospital Oldenburg, Department of Cardiology, Oldenburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hlc.2017.04.002DOI Listing
March 2018

Effectiveness and safety of outpatient rivaroxaban versus warfarin for treatment of venous thromboembolism in patients with a known primary hypercoagulable state.

Thromb Res 2018 03 31;163:132-137. Epub 2018 Jan 31.

Thrombosis Research Unit, Department of Medicine I, Division Hematology, University Hospital "Carl Gustav Carus" Dresden, Fetscherstrasse 74, D-01307 Dresden, Germany; Kings Thrombosis Service, Department of Hematology, Kings College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2018.01.046DOI Listing
March 2018

Cost-utility of empagliflozin in patients with type 2 diabetes at high cardiovascular risk.

J Diabetes Complications 2018 02 14;32(2):210-215. Epub 2017 Oct 14.

Medical University of South Carolina, College of Pharmacy, Charleston, SC, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jdiacomp.2017.10.006DOI Listing
February 2018

External Validation of the Hestia Criteria for Identifying Acute Pulmonary Embolism Patients at Low Risk of Early Mortality.

Clin Appl Thromb Hemost 2017 Oct 25;23(7):769-774. Epub 2016 May 25.

1 Department of Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1076029616651147DOI Listing
October 2017

Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.

Thromb Haemost 2017 10 22;117(10):1841-1847. Epub 2017 Jun 22.

Craig I. Coleman, PharmD, Professor of Pharmacy Practice, University of Connecticut, School of Pharmacy, 69 North Eagleville Road, Unit 3092, Storrs, CT 06269, USA, Tel.: +1 860 972 2096, Fax: +1 860 545 2277, E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH17-03-0210DOI Listing
October 2017

External validation of a claims-based and clinical approach for predicting post-pulmonary embolism outcomes among United States veterans.

Intern Emerg Med 2017 Aug 9;12(5):613-619. Epub 2017 Feb 9.

School of Pharmacy, University of Connecticut, 69 North Eagleville Road, Unit 3092, Storrs, CT, 06269, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11739-017-1625-9DOI Listing
August 2017

Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.

Stroke 2017 08 27;48(8):2142-2149. Epub 2017 Jun 27.

From the University of Connecticut School of Pharmacy, Storrs (C.I.C.); Department of Emergency Medicine, Baylor College of Medicine, Houston, TX (W.F.P.); Crystal Run Healthcare, Middletown, NY (T.J.B.); Ayer Neuroscience Institute, Hartford HealthCare, CT (M.J.A.); and Department of Neurology, Hartford Hospital, CT (M.J.A.).

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/STROKEAHA.117.017474
Publisher Site
http://dx.doi.org/10.1161/STROKEAHA.117.017474DOI Listing
August 2017

Overall Effectiveness of Rivaroxaban in Patients with Pulmonary Embolism.

Clin Ther 2017 Jul 23;39(7):1426-1436.e2. Epub 2017 Jun 23.

Janssen Scientific Affairs, LLC, Raritan, New Jersey.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinthera.2017.06.002DOI Listing
July 2017

Hospital length-of-stay and costs among pulmonary embolism patients treated with rivaroxaban versus parenteral bridging to warfarin.

Intern Emerg Med 2017 Apr 18;12(3):311-318. Epub 2016 Oct 18.

School of Pharmacy, University of Connecticut, 69 North Eagleville Road, Storrs, CT, 06269, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11739-016-1552-1DOI Listing
April 2017

Healthcare costs associated with rivaroxaban or warfarin use for the treatment of venous thromboembolism.

J Med Econ 2017 Feb 26;20(2):200-203. Epub 2016 Oct 26.

c Janssen Scientific Affairs, LLC , Raritan , NJ , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13696998.2016.1243544DOI Listing
February 2017

Real-world evidence of stroke prevention in patients with nonvalvular atrial fibrillation in the United States: the REVISIT-US study.

Curr Med Res Opin 2016 12 20;32(12):2047-2053. Epub 2016 Sep 20.

g Arrhythmia and Electrophysiology Research Center, Humanitas Clinical and Research Center , Rozzano , MI , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/03007995.2016.1237937DOI Listing
December 2016

Meta-analysis of ascorbic acid for prevention of postoperative atrial fibrillation after cardiac surgery.

Am J Health Syst Pharm 2016 Dec 2;73(24):2056-2066. Epub 2016 Nov 2.

Department of Pharmacy Practice, School of Pharmacy, University of Connecticut, Storrs, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2146/ajhp160066DOI Listing
December 2016

Outcomes associated with observation stays versus inpatient admissions for pulmonary embolism.

J Thromb Thrombolysis 2016 Nov;42(4):513-9

School of Pharmacy, University of Connecticut, 69 North Eagleville Road, Storrs, CT, 06269, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11239-016-1391-yDOI Listing
November 2016

Quality measures for anticoagulation care.

Curr Med Res Opin 2016 Oct 11;32(10):1685-1692. Epub 2016 Jul 11.

a University of Connecticut School of Pharmacy , Storrs , CT , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/03007995.2016.1200020DOI Listing
October 2016

Rivaroxaban versus Heparin Bridging to Warfarin Therapy: Impact on Hospital Length of Stay and Treatment Costs for Low-Risk Patients with Pulmonary Embolism.

Pharmacotherapy 2016 10 19;36(10):1109-1115. Epub 2016 Sep 19.

Department of Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, Connecticut.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/phar.1828DOI Listing
October 2016

Impact of Switching From a Vitamin K Antagonist to Rivaroxaban on Satisfaction With Anticoagulation Therapy: The XANTUS-ACTS Substudy.

Clin Cardiol 2016 Oct 30;39(10):565-569. Epub 2016 Jun 30.

Cardiovascular and Cell Sciences Research Institute, St George's, University of London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/clc.22565DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6490868PMC
October 2016

Rivaroxaban real-world evidence: Validating safety and effectiveness in clinical practice.

Thromb Haemost 2016 Sep 14;116(Suppl. 2):S13-S23. Epub 2016 Sep 14.

Jan Beyer-Westendorf, Center for Vascular Medicine, University Hospital "Carl Gustav Carus", Technical University Dresden, Fetscherstrasse 74, 01307 Dresden, Germany, Tel.: +49 351 4583659, E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH16-06-0485DOI Listing
September 2016

Impact of once- or twice-daily dosing frequency on adherence to chronic cardiovascular disease medications: A meta-regression analysis.

Int J Cardiol 2016 Aug 1;216:104-9. Epub 2016 May 1.

University of Connecticut School of Pharmacy, Storrs, CT, USA; University of Connecticut/Hartford Hospital Evidence-Based Practice Center, Hartford, CT, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2016.04.082DOI Listing
August 2016

Outcomes related to variation in hospital pulmonary embolus observation stay utilization.

Hosp Pract (1995) 2016 Aug 27;44(3):133-7. Epub 2016 May 27.

d Department of Emergency Medicine , University of Cincinnati , Cincinnati , OH , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/21548331.2016.1189302DOI Listing
August 2016

Doses of apixaban and rivaroxaban prescribed in real-world United States cardiology practices compared to registration trials.

Curr Med Res Opin 2016 07 1;32(7):1277-9. Epub 2016 Apr 1.

a University of Connecticut/Hartford Hospital Health Outcomes, Policy and Evidence Synthesis Group , Hartford , CT , U.S.A. ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/03007995.2016.1170672DOI Listing
July 2016

Association between once- and twice-daily direct oral anticoagulant adherence in nonvalvular atrial fibrillation patients and rates of ischemic stroke.

Int J Cardiol 2016 Jul 4;215:11-3. Epub 2016 Apr 4.

University of Connecticut, School of Pharmacy, Storrs, CT, USA; Hartford Hospital Evidence-Based Practice Center, Hartford, CT, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2016.03.212DOI Listing
July 2016

Rates of major bleeding with rivaroxaban in real-world studies of nonvalvular atrial fibrillation patients: a meta-analysis.

Curr Med Res Opin 2016 06 16;32(6):1117-20. Epub 2016 Mar 16.

a University of Connecticut School of Pharmacy , Storrs , CT , USA ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/03007995.2016.1161610DOI Listing
June 2016

Association between weekend admission for intracerebral and subarachnoid hemorrhage and in-hospital mortality.

Int J Cardiol 2016 Jun 16;212:26-8. Epub 2016 Mar 16.

University of Connecticut School of Pharmacy, Storrs, CT, United States; Hartford Hospital Evidence-Based Practice Center, Hartford, CT, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2016.03.022DOI Listing
June 2016

Vitamin K antagonist use: evidence of the difficulty of achieving and maintaining target INR range and subsequent consequences.

Thromb J 2016 13;14:14. Epub 2016 Jun 13.

Department of Pharmacy Practice, University of Connecticut School of Pharmacy, 69 N. Eagleville Road, Storrs, CT 06269-3092 USA ; Hartford Hospital Division of Cardiology, 80 Seymour Street, Hartford, CT 06102-5037 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12959-016-0088-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906845PMC
June 2016

Effect of vital sign measurement timing on Pulmonary Embolism Severity Index (PESI) and simplified PESI 30-day mortality risk determination.

Thromb Res 2016 May 15;141:8-10. Epub 2016 Feb 15.

University of Connecticut/Hartford Hospital Evidence-Based Practice Center, Hartford, CT, USA; University of Saint Joseph School of Pharmacy, Hartford, CT, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2016.02.017DOI Listing
May 2016

Cost-Effectiveness of High-Dose Edoxaban Compared with Adjusted-Dose Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation Patients.

Pharmacotherapy 2016 May 27;36(5):488-95. Epub 2016 Apr 27.

University of Connecticut, School of Pharmacy, Storrs, Connecticut.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/phar.1746DOI Listing
May 2016

External validation of prognostic rules for early post-pulmonary embolism mortality: assessment of a claims-based and three clinical-based approaches.

Thromb J 2016 14;14. Epub 2016 Mar 14.

School of Pharmacy, University of Connecticut, 69 North Eagleville Road, Storrs, CT 06269 USA ; University of Connecticut/Hartford Hospital Evidence-Based Practice Center, Hartford, CT USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12959-016-0081-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790043PMC
March 2016

Mapping of Multiple Sclerosis Walking Scale (MSWS-12) to five-dimension EuroQol (EQ-5D) health outcomes: an independent validation in a randomized control cohort.

Patient Relat Outcome Meas 2016 3;7:13-8. Epub 2016 Feb 3.

Department of Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/PROM.S96956DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745957PMC
February 2016

Association between weekend admission for atrial fibrillation or flutter and in-hospital mortality, procedure utilization, length-of-stay and treatment costs.

Int J Cardiol 2016 Jan 25;202:427-9. Epub 2015 Sep 25.

University of Connecticut School of Pharmacy, Storrs, CT, USA; University of Connecticut/Hartford Hospital Evidence-Based Practice Center, Hartford, CT, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01675273153049
Publisher Site
http://dx.doi.org/10.1016/j.ijcard.2015.09.053DOI Listing
January 2016

AMSSM Scientific Statement Concerning Viscosupplementation Injections for Knee Osteoarthritis: Importance for Individual Patient Outcomes.

Clin J Sport Med 2016 Jan;26(1):1-11

*Division of Sports Medicine, Department of Family, Community and Preventive Medicine, Drexel University College of Medicine, Philadelphia, Pennsylvania; †Outpatient Musculoskeletal Rehabilitation, St Jude Medical Center, Fullerton, California; ‡Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio; §Maine Medical Center Sports Medicine, Portland, Maine; ¶Hartford Hospital Evidence-Based Practice Center, UCONN School of Pharmacy; and ‖Hartford Hospital Evidence-Based Practice Center, Hartford, Connecticut.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JSM.0000000000000274DOI Listing
January 2016

REal-LIfe Evidence of stroke prevention in patients with atrial Fibrillation--The RELIEF study.

Int J Cardiol 2016 Jan 25;203:882-4. Epub 2015 Sep 25.

Bayer Pharma AG, Wuppertal, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2015.09.037DOI Listing
January 2016

Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective.

BMJ Open 2015 Nov 6;5(11):e008861. Epub 2015 Nov 6.

University of Saint Joseph, School of Pharmacy, Hartford, Connecticut, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjopen-2015-008861DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636621PMC
November 2015